v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Operating activities:      
Net loss $ (1,384,134) $ (450,912)  
Reconciliation of net loss to net cash from operating activities:      
Depreciation and amortization 11,345 29,116  
Interest expense 3,467 102,296  
Share based compensation expense 52,280 94,544  
Extinguishment of debt 0 (459,912)  
Changes in non-cash working capital items      
Accounts receivable 155,880 5,800  
Prepaid expenses and other current assets 70,960 (99,252)  
Net book value of demonstration inventory sold 0 16,248  
Inventories (228,187) 90,851  
Accounts payable 121,743 66,518  
Accrued liabilities 147,428 7,766  
Deferred revenue (113,090) (21,146)  
Net cash used in operating activities (1,162,308) (618,083)  
Investing activities:      
Purchases of equipment 0 0  
Net cash used in investing activities 0 0  
Financing activities:      
Proceeds from convertible loans 500,000 0  
Proceeds from term loan 0 550,000  
Net cash provided by financing activities 500,000 550,000  
Effect of exchange rate changes on cash and cash equivalents (292) 1,322  
Net decrease in cash and cash equivalents (662,600) (66,761)  
Cash and cash equivalents, beginning of the period 1,991,377 608,348 $ 608,348
Cash and cash equivalents, end of the period $ 1,328,777 $ 541,587 $ 1,991,377

Source